Definium Therapeutics, Inc. Impairment of Intangible Assets, Finite-lived
Definium Therapeutics, Inc. (DFTX) reported Impairment of Intangible Assets, Finite-lived of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2025-03-06
- Definium Therapeutics, Inc. impairment of intangible assets, finite-lived for fiscal 2024 was $0.00.
- Definium Therapeutics, Inc. impairment of intangible assets, finite-lived for fiscal 2023 was $0.00.
- Definium Therapeutics, Inc. impairment of intangible assets, finite-lived for fiscal 2022 was $0.00.
- Definium Therapeutics, Inc. impairment of intangible assets, finite-lived for fiscal 2021 was $0.00.
| Period end | Impairment of Intangible Assets, Finite-lived 12 month |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-06 |
| 2023-12-31 | $0.00 10-K · filed 2025-03-06 |
| 2022-12-31 | $0.00 10-K · filed 2024-02-28 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cronos Group Inc. (CRON) | $1.223B | ||
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B |